Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

US Patent 10590179 · Granted Mar 17, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
Anti-GPC3 antibody2024
Universal anti-tag chimeric antigen receptor-expressing t cells and methods of t2024
Immunocompetent cell and expression vector expressing regulatory factors of immu2024
Medicine for treating cancer by administering a toll-like receptor agonist and L2023
Medicine for treating cancer by administering a toll-like receptor agonist and L2023
Anti-GPC3 antibody2023
Method for assisting prediction of risk of occurrence of side effect of irinotec2023